It is a major breakthrough for women across the world in the pursuit of beating cervical cancer as a vaccine called Gardasil has been produced by Australian of the Year; Professor Ian Frazer. In 2006, there were approximately 240 new cases and around75 deaths attributable to cervical cancer NSW. In a scheme to reduce these numbers, the Commonwealth Government will be providing the new vaccine, Gardasil, free to all women and girls aged between 12 and 26 through the National HPV Vaccination Program commencing in April/May 2007.
The following article was taken from The Sydney Morning Herald on 27 April 2007. It comments that “more than 230,000 school students were expected to be given the vaccine over the next two years.” It also says that:
“Gardasil protects against four strains of the common sexually transmitted virus, which can cause skin warts, genital warts and 70 per cent of cervical cancers.”
While some organisations have criticised the vaccine for only providing protection against a few strains, new studies have shown it may protect women from more strains than first thought:
In the article titled ”Extra protection” from The Advertiser on 19 April 2007:
“CSL said the drug may be effective against additional HPV types responsible for 10 per cent of cervical cancers.”
It also comments that:
“The company’s U.S. partner, Merck and Co, has sought government permission in that country to further test broader uses for the drug.”
These articles have several new values including timeliness, currency and impact as HPV touches four out of five women and is a major breakthrough to develop a vaccine that could reduce these numbers.
This would be a great news story as so many women are touched by HPV and therefore have an interest in it. It is also a story that has proximity as a news value due to the fact that an Australian developed the vaccine.